Consistent with our previous data (29), these results suggest that the induction of CD26 in myeloma cells by HDACi does not enhance CDC activity by CD26mAb against CD26neg myeloma cells (Fig. 2D). The gene discussed is DPP4; the disease is plasma cell myeloma.